Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth Force

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Oncology|December 19, 2022
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case reportTony Zibo Zhuang, Lara Harik, Seth Force, et al.
Clinical Endoscopy|February 11, 2022
Epidemiology of early esophageal adenocarcinomaThuy-Van P Hang, Zachary Spiritos, Anthony M Gamboa, et al.
The Oncologist|January 17, 2020
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database AnalysisMadhusmita Behera, Conor E Steuer, Yuan Liu, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal CancerNabil F Saba, Seth Force, Charley Staley, et al.
The Annals of Thoracic Surgery|October 24, 2021
Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for SimulationPhilip A Erwin, Andy C Lee, Usman Ahmad, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Oncology|December 19, 2022
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case reportTony Zibo Zhuang, Lara Harik, Seth Force, et al.
Clinical Endoscopy|February 11, 2022
Epidemiology of early esophageal adenocarcinomaThuy-Van P Hang, Zachary Spiritos, Anthony M Gamboa, et al.
The Oncologist|January 17, 2020
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database AnalysisMadhusmita Behera, Conor E Steuer, Yuan Liu, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal CancerNabil F Saba, Seth Force, Charley Staley, et al.
The Annals of Thoracic Surgery|October 24, 2021
Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for SimulationPhilip A Erwin, Andy C Lee, Usman Ahmad, et al.
Pageof 3